A clinical trial reveals that benralizumab, an injectable drug for severe asthma, outperforms steroids in reducing asthma and ...

What is benralizumab? Breakthrough asthma drug hailed a 'game-changer' - The injection is the first new treatment for asthma ...

Head and neck cancers are the seventh most common type of cancer worldwide, according to the 2020 World Cancer Report.

It is already used as a recurring treatment for severe asthma in low doses. However, the trial found that a single higher ...

From tumor necrosis factor alpha (TNF-α), to IL-17 inhibitors, and then to IL-23 inhibitors, biologics have brought new light to the treatment of psoriasis again. In recent years, the exploration of ...

Discover how ADCs are advancing oncology, the regulatory challenges they face, and the promise they hold for the future of ...

Laekna, Inc. (2105.HK) (“Laekna”), a global biotech company focused on novel drug development for metabolic and cancer ...

The European Commission’s decision is based on two Phase III trials where Tevimbra plus chemotherapy improved overall ...

Dr. Reddy's Laboratories has announced the launch of Toripalimab in India. This drug is designed to treat adults suffering ...

"Alector stock drops after Alzheimer’s drug fails in Phase II trial" was originally created and published by Clinical Trials ...

SINTBILO® (tafolecimab injection), developed independently by Innovent, is a fully human lgG2 monoclonal antibody that can specifically bind to PCSK9, reducing LDL-C levels by inhibiting ...

Zenyaku Kogyo receives Japanese approval for anti-CD20 monoclonal antibody, Rituxan to treat chronic ITP in children: Tokyo Saturday, November 23, 2024, 10:00 Hrs [IST] Zenyaku Ko ...